Glucocorticoid and mineralocorticoid receptor agonists/antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C03 DIURETICS
C03D ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS
C03DA Aldosterone antagonists
C03DA04 Eplerenone
D01115 Eplerenone (JP18/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Mineralocorticoid Receptor Antagonist
Eplerenone
D01115 Eplerenone (JP18/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D01115 Eplerenone (JP18/USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG03231 Antihypertensive
DG01676 Aldosterone antagonist
D01115 Eplerenone
DG01885 Potassium-sparing diuretic
D01115 Eplerenone
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D01115 Eplerenone
Drug classes [BR:br08332]
Cardiovascular agent
DG01676 Aldosterone antagonist
D01115 Eplerenone
DG03231 Antihypertensive
D01115 Eplerenone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C2 (MR)
D01115 Eplerenone (JP18/USAN/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01115 Eplerenone
D01115 Eplerenone tablets
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01115
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01115
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01115
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01115